5D Library › Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics · 中文

Chapter 4. Downregulation and the Tolerance Ratchet: Each Dose Less, the Total More

The part that is known

Evidence

Receptor downregulation and tolerance (animal and human). Repeated LSD selectively downregulates 5-HT2 receptors in rat brain, as Buckholtz and colleagues reported in 1990 (Buckholtz et al. 1990). Gresch and colleagues found behavioural tolerance associated with reduced cortical 5-HT2A signalling and linked the two (Gresch et al. 2005). In humans, Isbell and colleagues observed the development of tolerance during continuous administration as early as 1956 (Isbell et al. 1956). Nichols’s review collects this literature (Nichols 2016).

Note

The exposure levels behind that evidence. The animal experiments and early human observations above used exposures far above the range this book discusses. That receptor downregulation occurs at high exposure is evidenced; the human 5-HT2A recovery half-life at sub-perceptual exposure has not been measured. Every table in this chapter says what would follow from a given recovery half-life, not what any schedule should be.

The mathematics of the ratchet

Writing the surface receptor density RR as the sum of synthesis, constitutive degradation and occupancy-driven internalisation, with RR normalised so that the drug-free steady state is 1:

dRdt=ksyn−kdegR−kintO(Ce)R.\frac{dR}{dt} = k_{\text{syn}} – k_{\text{deg}}R – k_{\text{int}}\,O(C_e)\,R .

Calculation

# Chapter 4. Receptor downregulation under repeated exposure: the "tolerance
# ratchet". Surface receptor density R obeys synthesis, constitutive
# degradation, and internalisation driven by occupancy:
#   dR/dt = ksyn - kdeg R - kint O(Ce) R
#   O(Ce) = Ce / (Ce + 1)                      (p01, h = 1, dimensionless)
# with R normalised so that the drug-free steady state is 1. Exposure is the
# effect-site curve of p04 repeated on a schedule. Time is in days; the
# receptor recovery half-life tau_R is the parameter that decides everything,
# and it is the one measured only in animals at much higher exposures (Chapter
# 4 text). Author's model; dimensionless units.
import math

DT = 0.002                    # days
# receptor recovery half-life, days (illustrative)
TAU_R = 3.0
KDEG = math.log(2.0) / TAU_R
KSYN = KDEG                   # so that drug-free steady state R = 1
# internalisation rate at full occupancy, per day
KINT = 2.0
KE_CE = math.log(2.0) / 0.25  # effect-site clearance: 6-hour half-life

def run(dose_fraction, interval_days, n_doses, tail_days=30.0, tau_r=TAU_R):
    kdeg = math.log(2.0) / tau_r
    ksyn = kdeg
    R, Ce = 1.0, 0.0
    t_end = interval_days * n_doses + tail_days
    doses = [i * interval_days for i in range(n_doses)]
    di, R_at_dose, Rmin = 0, [], 1.0
    n = int(t_end / DT)
    for i in range(n):
        t = i * DT
        if di < len(doses) and t >= doses[di] - DT / 2:
            R_at_dose.append(R)
            Ce += dose_fraction          # instantaneous input, dimensionless
            di += 1
        O = Ce / (Ce + 1.0)
        R += DT * (ksyn - kdeg * R - KINT * O * R)
        Ce += DT * (-KE_CE * Ce)
        Rmin = min(Rmin, R)
    return R_at_dose, Rmin, R

if __name__ == "__main__":
    print("Receptor density normalised to 1 without drug. Recovery half-life"
          " {:.1f} days.".format(TAU_R))
    print(
        "Dose fraction 0.5 in the dimensionless units of p01 (occupancy"
        " ~0.33).\n"
    )
    print("   interval (days)  R before dose 1, 2, 3, 5, 10     R at dose 10"
          "  minimum R")
    for iv in (1.0, 2.0, 3.0, 5.0, 7.0):
        Rd, Rmin, Rend = run(0.5, iv, 10)
        picks = [Rd[k] for k in (0, 1, 2, 4, 9)]
        print(
            "   {:15.1f}  ".format(iv)
            + " ".join("{:.3f}".format(v) for v in picks)
            + "{:12.3f} {:10.3f}".format(Rd[9], Rmin)
        )

    print(
        "\nThe ratchet is visible in the columns: at a 1-day interval the"
        " density"
    )
    print(
        "before each dose keeps falling and settles well below 1, while at a"
        " 7-day"
    )
    print(
        "interval it returns almost to 1 before the next dose. The quantity"
        " that"
    )
    print(
        "decides which happens is the ratio of the recovery half-life to the"
        " dosing"
    )
    print("interval, not the amount.")

    print(
        "\nSteady-state pre-dose density against interval, for three recovery"
    )
    print("half-lives (dose fraction held at 0.5, 20 doses):")
    print("   interval   tau_R = 1 d   tau_R = 3 d   tau_R = 7 d")
    for iv in (1.0, 2.0, 3.0, 4.0, 5.0, 7.0, 10.0):
        row = []
        for tau in (1.0, 3.0, 7.0):
            Rd, _, _ = run(0.5, iv, 20, tau_r=tau)
            row.append(Rd[-1])
        print("   {:8.1f} {:13.3f} {:13.3f} {:13.3f}".format(iv, *row))

    print(
        "\nRead the tau_R = 7 d column: even a 10-day interval leaves the"
        " density"
    )
    print(
        "below 1. With a recovery half-life longer than the interval, every"
        " dose"
    )
    print(
        "starts from a lower density than the last, and the sequence"
        " converges to a"
    )
    print(
        "new steady state - the ratchet. The critical interval, defined as"
        " the one"
    )
    print("at which the steady-state pre-dose density is 0.95:")
    for tau in (1.0, 3.0, 7.0):
        lo, hi = 0.2, 60.0
        for _ in range(45):
            mid = 0.5 * (lo + hi)
            Rd, _, _ = run(0.5, mid, 20, tau_r=tau)
            if Rd[-1] < 0.95:
                lo = mid
            else:
                hi = mid
        print("   tau_R = {:4.1f} days -> critical interval {:5.1f} days"
              .format(tau, hi))

    print(
        "\nThe honest point about all of this: tau_R for 5-HT2A in humans at"
    )
    print(
        "sub-perceptual exposures is not measured. The animal literature that"
    )
    print(
        "establishes downregulation used repeated exposures far above"
        " these, and"
    )
    print(
        "the recovery half-life at low occupancy need not be the same. So the"
        " table"
    )
    print(
        "above is a map of what WOULD follow from a given tau_R, and the"
        " schedules"
    )
    print("recommended in popular accounts cannot be derived from it.")
# Receptor density normalised to 1 without drug. Recovery half-life 3.0 days.
# Dose fraction 0.5 in the dimensionless units of p01 (occupancy ~0.33).
#
#    interval (days)  R before dose 1, 2, 3, 5, 10     R at dose 10  minimum R
#                1.0  1.000 0.796 0.666 0.541 0.476       0.476      0.440
#                2.0  1.000 0.824 0.741 0.684 0.668       0.668      0.582
#                3.0  1.000 0.860 0.807 0.780 0.776       0.776      0.655
#                5.0  1.000 0.911 0.891 0.885 0.884       0.884      0.725
#                7.0  1.000 0.944 0.936 0.935 0.935       0.935      0.756
#
# The ratchet is visible in the columns: at a 1-day interval the density
# before each dose keeps falling and settles well below 1, while at a 7-day
# interval it returns almost to 1 before the next dose. The quantity that
# decides which happens is the ratio of the recovery half-life to the dosing
# interval, not the amount.
#
# Steady-state pre-dose density against interval, for three recovery
# half-lives (dose fraction held at 0.5, 20 doses):
#    interval   tau_R = 1 d   tau_R = 3 d   tau_R = 7 d
#         1.0         0.745         0.471         0.272
#         2.0         0.892         0.667         0.441
#         3.0         0.951         0.776         0.559
#         4.0         0.977         0.842         0.642
#         5.0         0.989         0.884         0.704
#         7.0         0.997         0.935         0.789
#        10.0         1.000         0.970         0.864
#
# Read the tau_R = 7 d column: even a 10-day interval leaves the density
# below 1. With a recovery half-life longer than the interval, every dose
# starts from a lower density than the last, and the sequence converges to a
# new steady state - the ratchet. The critical interval, defined as the one
# at which the steady-state pre-dose density is 0.95:
#    tau_R =  1.0 days -> critical interval   3.0 days
#    tau_R =  3.0 days -> critical interval   8.0 days
#    tau_R =  7.0 days -> critical interval  18.2 days
#
# The honest point about all of this: tau_R for 5-HT2A in humans at
# sub-perceptual exposures is not measured. The animal literature that
# establishes downregulation used repeated exposures far above these, and
# the recovery half-life at low occupancy need not be the same. So the table
# above is a map of what WOULD follow from a given tau_R, and the schedules
# recommended in popular accounts cannot be derived from it.

The ratchet is directly visible in the table. With a recovery half-life τR=3\tau_R = 3 days, the pre-dose density at a one-day interval keeps falling and settles well below 1, while at a seven-day interval it returns almost to 1. The second table generalises this: what decides the outcome is the ratio of the recovery half-life to the dosing interval, not the size of the amount. At τR=7\tau_R = 7 days even a ten-day interval stays below 1.

The program closes by finding, by bisection, the “critical interval” — the one at which the steady-state pre-dose density reaches 0.95: 3.0 days at τR=1\tau_R = 1 day, 8.0 days at 3 days, and 18.2 days at 7 days.

Receptor density under repeated exposure. Left: with a recovery half-life of 3 days, the evolution of pre-dose density at one-, three- and seven-day intervals; the tighter the interval, the deeper the ratchet. Right: steady-state pre-dose density against interval, for recovery half-lives of 1, 3 and 7 days. The horizontal line marks 0.95.

Note

This section has exactly one conclusion, and it is conditional: if the recovery half-life were known, the critical interval would be the table above. Since it is not known, the schedules that circulate in popular accounts in the form “every three days” or “every four days” cannot be derived from receptor downregulation. They may rest on other grounds — experience, convenience, risk reduction — but not on this piece of pharmacology.

Each dose less, the total more

Now the chapter’s second result, which runs opposite to the usual inference.

Calculation

# Chapter 4. From receptor loss to effect loss, and the schedule that makes a
# difference. The effect of a dose is taken proportional to R * O(Ce)
# integrated over the dose, where R is the surface density from p06 and O the
# occupancy from p01. Two things then follow that are worth separating: (a)
# effect per dose declines as R ratchets down, and (b) the CUMULATIVE effect
# over a fixed calendar period can still be higher on a tighter schedule even
# though each dose does less. Popular accounts conflate these. Dimensionless.
import math

DT = 0.002
KINT, KE_CE = 2.0, math.log(2.0) / 0.25

def course(dose_fraction, interval_days, n_doses, tau_r=3.0, horizon=None):
    kdeg = math.log(2.0) / tau_r
    ksyn = kdeg
    R, Ce = 1.0, 0.0
    t_end = horizon if horizon is not None else interval_days * n_doses + 20.0
    doses = [
        i * interval_days for i in range(n_doses) if i * interval_days < t_end
    ]
    per_dose = [0.0] * len(doses)
    di, cur = 0, -1
    total = 0.0
    for i in range(int(t_end / DT)):
        t = i * DT
        if di < len(doses) and t >= doses[di] - DT / 2:
            cur = di
            Ce += dose_fraction
            di += 1
        O = Ce / (Ce + 1.0)
        signal = R * O
        total += signal * DT
        if cur >= 0:
            per_dose[cur] += signal * DT
        R += DT * (ksyn - kdeg * R - KINT * O * R)
        Ce += DT * (-KE_CE * Ce)
    return per_dose, total

if __name__ == "__main__":
    print("Effect signal = R x occupancy, integrated.")
    print("Dose fraction 0.5, tau_R = 3 days.\n")
    print("   interval (days)  effect of dose 1   dose 5   dose 10"
          "  dose 10 / dose 1")
    for iv in (1.0, 2.0, 3.0, 5.0, 7.0):
        pd, _ = course(0.5, iv, 10)
        print("   {:15.1f} {:17.4f} {:8.4f} {:9.4f} {:17.3f}"
              .format(iv, pd[0], pd[4], pd[9], pd[9] / pd[0]))

    print(
        "\nEach dose does less than the one before, and the loss is larger on"
        " tighter"
    )
    print(
        "schedules: at a 1-day interval the tenth dose produces {:.0%} of the"
        " first,".format(
            course(0.5, 1.0, 10)[0][9] / course(0.5, 1.0, 10)[0][0]
        )
    )
    print(
        "at a 7-day interval {:.0%}. That is tolerance in the ordinary sense."
        .format(course(0.5, 7.0, 10)[0][9] / course(0.5, 7.0, 10)[0][0])
    )

    print(
        "\nBut now hold the CALENDAR PERIOD fixed at 42 days and vary the"
        " schedule:"
    )
    print("   interval (days)   doses in 42 d   cumulative effect   per dose")
    rows = []
    for iv in (1.0, 2.0, 3.0, 4.0, 6.0, 7.0, 14.0):
        n = int(42.0 / iv)
        pd, total = course(0.5, iv, n, horizon=42.0)
        rows.append((iv, n, total, total / n))
        print(
            "   {:15.1f} {:15d} {:19.3f} {:10.4f}".format(
                iv, n, total, total / n
            )
        )

    best = max(rows, key=lambda r: r[2])
    print(
        "\n   Cumulative effect over the fixed period is greatest at the"
        " {:.0f}-day".format(best[0])
    )
    print(
        "   interval ({:.3f}), even though the effect per dose there is the"
        " lowest".format(best[2])
    )
    print(
        "   ({:.4f} against {:.4f} at the 14-day interval). So 'tolerance"
        " builds up'".format(best[3], rows[-1][3])
    )
    print(
        "   and 'a tighter schedule delivers less in total' are different"
        " claims,"
    )
    print(
        "   and in this model the second is false. Any argument for spacing"
        " doses"
    )
    print(
        "   that rests only on receptor downregulation therefore does not go"
    )
    print(
        "   through: downregulation reduces the effect PER DOSE while"
        " leaving the"
    )
    print(
        "   total over a period higher, and which of those matters depends on"
        " what"
    )
    print(
        "   the practice is for - a question the pharmacology cannot answer."
    )

    print(
        "\nSensitivity to the one parameter that is not measured, tau_R,"
        " with the"
    )
    print("calendar period and total doses held fixed (14 doses in 42 days):")
    print("   tau_R (days)   dose 14 / dose 1   cumulative effect")
    for tau in (0.5, 1.0, 3.0, 7.0, 14.0):
        pd, total = course(0.5, 3.0, 14, tau_r=tau, horizon=42.0)
        print(
            "   {:12.1f} {:18.3f} {:19.3f}".format(tau, pd[13] / pd[0], total)
        )
    print(
        "\n   Across plausible recovery half-lives the ratio of the last dose"
        " to the"
    )
    print(
        "   first ranges from near 1 to well under a half. The schedules in"
        " popular"
    )
    print("   accounts are stated as though tau_R were known; it is not.")
# Effect signal = R x occupancy, integrated.
# Dose fraction 0.5, tau_R = 3 days.
#
#    interval (days)  effect of dose 1   dose 5   dose 10  dose 10 / dose 1
#                1.0            0.1194   0.0718    0.0703             0.589
#                2.0            0.1277   0.0911    0.0897             0.702
#                3.0            0.1283   0.1026    0.1021             0.796
#                5.0            0.1283   0.1148    0.1148             0.895
#                7.0            0.1283   0.1207    0.1206             0.940
#
# Each dose does less than the one before, and the loss is larger on tighter
# schedules: at a 1-day interval the tenth dose produces 59% of the first,
# at a 7-day interval 94%. That is tolerance in the ordinary sense.
#
# But now hold the CALENDAR PERIOD fixed at 42 days and vary the schedule:
#    interval (days)   doses in 42 d   cumulative effect   per dose
#                1.0              42               2.826     0.0673
#                2.0              21               1.946     0.0927
#                3.0              14               1.471     0.1051
#                4.0              10               1.124     0.1124
#                6.0               7               0.840     0.1200
#                7.0               6               0.733     0.1221
#               14.0               3               0.382     0.1274
#
#    Cumulative effect over the fixed period is greatest at the 1-day
#    interval (2.826), even though the effect per dose there is the lowest
#    (0.0673 against 0.1274 at the 14-day interval). So 'tolerance builds up'
#    and 'a tighter schedule delivers less in total' are different claims,
#    and in this model the second is false. Any argument for spacing doses
#    that rests only on receptor downregulation therefore does not go
#    through: downregulation reduces the effect PER DOSE while leaving the
#    total over a period higher, and which of those matters depends on what
#    the practice is for - a question the pharmacology cannot answer.
#
# Sensitivity to the one parameter that is not measured, tau_R, with the
# calendar period and total doses held fixed (14 doses in 42 days):
#    tau_R (days)   dose 14 / dose 1   cumulative effect
#             0.5              0.995               1.857
#             1.0              0.962               1.766
#             3.0              0.796               1.471
#             7.0              0.577               1.150
#            14.0              0.389               0.907
#
#    Across plausible recovery half-lives the ratio of the last dose to the
#    first ranges from near 1 to well under a half. The schedules in popular
#    accounts are stated as though tau_R were known; it is not.

The first table is the part the usual inference rests on: each dose has a smaller effect than the last, and the loss is greater on tighter schedules. That is tolerance.

The second table holds the calendar period fixed at 42 days and lets the schedule vary. The cumulative effect is greatest on the tightest schedule (a one-day interval, 2.826), where the effect per dose is smallest (0.0673, against 0.1274 at the fourteen-day interval).

So “tolerance accumulates” and “a tighter schedule delivers less in total” are different claims, and in this model the second is false. Hence

receptor downregulation alone cannot argue for spacing doses out. What downregulation lowers is the effect per dose, while the cumulative effect is higher; which of those matters depends on what the practice is for — and the pharmacology cannot answer that.

Note

This is not a recommendation of a tight schedule. The book recommends no schedule. What this section says is that an argument fails: one cannot get from receptor downregulation to “spacing doses out is better”. Spacing may well be better for other reasons — reducing the cumulative risk of adverse events, reducing the possibility of dependence, or leaving time for the “practice input” of Chapter 6 to occur. Those are different arguments and need their own evidence.

The program’s last section gives the sensitivity to τR\tau_R: with the calendar period and the number of doses held fixed, the ratio of the last dose’s effect to the first ranges from near 1 (τR=0.5\tau_R = 0.5 days) to 0.389 (τR=14\tau_R = 14 days). That range spans “almost no tolerance” to “marked tolerance”, and distinguishing them requires the unmeasured parameter.

Hypothesis · not established

The author’s hypothesis (not established): under repeated sub-perceptual exposure, the fall in 5-HT2A receptor density is smaller than an extrapolation proportional to occupancy from high exposure would predict, because the internalisation rate is not a linear function of occupancy at low occupancy. What would show it to be wrong: in a receptor-imaging study under regulatory authorisation (positron emission tomography with a 5-HT2A radioligand, for instance), finding that the fall in receptor binding after repeated low exposure significantly exceeds the linear extrapolation; a 95 % confidence interval for the difference that includes zero would leave the hypothesis unsupported rather than refuted.

Summary

Repeated high exposure downregulates 5-HT2 receptors in rat brain, behavioural tolerance is associated with reduced cortical signalling, and human tolerance was observed in 1956. But those exposures are far above the range discussed here, and the human recovery half-life at sub-perceptual exposure has not been measured. The mathematics of the ratchet shows that what decides the outcome is the ratio of the recovery half-life to the dosing interval: the critical interval is 3.0, 8.0 and 18.2 days at τR\tau_R of 1, 3 and 7 days. Since τR\tau_R is unknown, the specific schedules in popular accounts cannot be derived from downregulation. The chapter’s second result runs opposite to the usual inference: over a fixed calendar period a tighter schedule lowers the effect per dose while raising the cumulative effect, so downregulation alone cannot argue for spacing doses out; which quantity matters depends on the purpose, which pharmacology does not address. Finally, with the calendar period and dose count fixed, the ratio of last dose to first ranges with τR\tau_R from near 1 to 0.389.

References

Buckholtz, Neil S., Da Fu Zhou, Daniel X. Freedman, and William Z. Potter. 1990. “Lysergic Acid Diethylamide (LSD) Administration Selectively Downregulates Serotonin2_2 Receptors in Rat Brain.” Neuropsychopharmacology 3 (2): 137–48.
Gresch, Paul J., Randy L. Smith, Jeffrey T. McCracken, Robert J. Barrett, and Elaine Sanders-Bush. 2005. “Behavioral Tolerance to Lysergic Acid Diethylamide Is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex.” Neuropsychopharmacology 30 (9): 1693–1702. https://doi.org/10.1038/sj.npp.1300711.
Isbell, Harris, R. E. Belleville, H. F. Fraser, A. Wikler, and C. R. Logan. 1956. “Studies on Lysergic Acid Diethylamide (LSD-25): Effects in Former Morphine Addicts and Development of Tolerance During Chronic Intoxication.” AMA Archives of Neurology and Psychiatry 76 (5): 468–78. https://doi.org/10.1001/archneurpsyc.1956.02330290012002.
Nichols, David E. 2016. “Psychedelics.” Pharmacological Reviews 68 (2): 264–355. https://doi.org/10.1124/pr.115.011478.

Fan, Y. (2026). Biomathematical Models of Sub-Perceptual Tryptamine Pharmacokinetics, 5-HT2A Receptor Desensitisation and Neuroplastic Window Dynamics: From Michaelis–Menten Kinetics of Prodrug Deacetylation and Whole-Brain Connectivity Entropy to the Microdose Tolerance Ratchet, with a Textual Examination of the Dose Boundary in the Classical Materia Medica [亚知觉色胺药代动力学、5-HT2A 受体脱敏与神经可塑性窗口的生物数学模型] (Version 1.0.0). 5D Library. https://doi.org/10.5281/zenodo.24019347 · Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).